About Ellex
Ellex is a Healthcare company based in Adelaide (Australia) founded in 1985, and was acquired by Quantel Medical in July 2020. It develops products for the treatment of eye diseases. Ellex has completed 1 acquisition, including iScience Interventional. Its Indian entity Lumibird Medical India Private Limited reported revenue of ₹12.3 Lakh. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy.
Company details
Ellex was founded in 1985 in Adelaide, Australia, within the ophthalmology sector. Ultrasound systems are developed by the company for ophthalmologists to diagnose and treat eye diseases. Products are offered for procedures including selective laser trabeculoplasty, canaloplasty, vitreolysis, capsulotomy, photocoagulation, and retinal rejuvenation. The canaloplasty business of iScience Interventional, a US-based firm, was acquired in 2014.
- Headquarters Adelaide, Australia
- Stage Acquired
- SectorsHealthcare
- Website ellex.com
- Social LinkedIn Facebook YouTube
- Acquired by Quantel Medical (Jul 2020)
- Legal Name Lumibird Medical India Private Limited
- Date of Incorporation 19 Apr, 2022
- Indian entity revenue₹12.3 Lakh
FY 2024 · +112% YoY
- Indian entity net profit₹57,542
FY 2024 · 5% margin
- Indian entity EBITDA₹83,008
FY 2024 · 7% margin
- Latest Funding Round$24.37M (USD), Post-IPO
Nov 2017
- InvestorsQuantel Medical
& 1 more
- Investments & Acquisitions
- Acquired byQuantel Medical
(Jul 2020)
Associated legal entities of Ellex
Ellex operates through Lumibird Medical India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lumibird Medical India Private Limited CIN U51909MH2022FTC380805 | Active | 19 Apr 2022 | Mumbai, Maharashtra | ₹0.1 Cr | 2 | View details |
Apps and channels of Ellex
its YouTube channel Lumibird Medical - Quantel Medical & Ellex has 4.8K subscribers and 30 videos.
Videos from Ellex
The most watched videos on Ellex's YouTube channel, Lumibird Medical - Quantel Medical & Ellex (4.8K subscribers). Click a video to play it here.
Funding Insights of Ellex
- Total Rounds 5
- Last Round Post-IPO — $24.37M
- First Round $5.5M
(Jun 2007)
- Investors Count 1
All 5 funding rounds of Ellex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $24.37M | Post-IPO | – | – | – |
| Dec 2016 | $10.3M | Post-IPO | – | – | – |
| Aug 2016 | $2.5M | Grant | – | – | |
| Apr 2016 | $5M | Post-IPO | – | – | – |
| Jun 2007 | $5.5M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Ellex
Ellex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Quantel Medical and business.gov.au.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support is provided for businesses in Australia through government resources. | business.gov.au | Australia | ||
Ultrasound and laser devices for ophthalmology are manufactured and marketed. | 1993 | quantel-medical.com | Cournon, France |
Investor details for Ellex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Lumibird Medical India Private Limited (Ellex)
Lumibird Medical India Private Limited is the primary company behind Ellex. The board of Lumibird Medical India Private Limited currently have 2 directors; the longest-serving is Jean Marc Francis Gendre, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jean Marc Francis Gendre DIN 09576466 | Director | 19 Apr 2022 | 4 yrs 6 mo | Lumibird Medical India Private Limited |
| Jatin Rameshchandra Desai DIN 09576467 | Director | 19 Apr 2022 | 4 yrs 6 mo | Lumibird Medical India Private Limited |
Financials of Ellex
Figures of Lumibird Medical India Private Limited, the primary company behind Ellex, for FY 2024. Revenue was ₹12.3 Lakh (+112% year on year). Net profit was ₹57,542 (5% margin). EBITDA was ₹83,008 (7% margin).
- ₹12.3 LakhRevenue · FY 2024 · +112% YoY
- ₹57,542Net profit · 5% margin
- ₹83,008EBITDA · 7% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Lumibird Medical India Private Limited are on its company page.
Detailed financial statements for Ellex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ellex
Ellex has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include iScience Interventional.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Microcatheter and imaging technologies for ophthalmic procedures are developed. | iscienceinterventional.com | Menlo Park, United States | 1999 | Jan 2014 | •••• |
Complete acquisition details for Ellex
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ellex
6 dated milestones of Ellex across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Ellex is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.5M.
- Acquisition Acquires iScience Interventional.
- Funding Latest funding round, Post-IPO, of $24.4M.
- Exit Acquired by Quantel Medical.
Web traffic of Ellex
The website of Ellex (ellex.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 50.7% vs previous month
Websites whose visitors overlap most with Ellex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ziehm.com | 100% | 8.8K | #2,507,043 | View details | |
lajollalaservision.com | lajollalaservision.com | 62% | – | ||
vsri.ucdavis.edu | vsri.ucdavis.edu | 62% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ellex
Complete news archive for Ellex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ellex
Ellex was founded in 1985 and raised its 1st funding round 22 years after it was founded.
Ellex is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.
The primary company behind Ellex, Lumibird Medical India Private Limited, reported revenue of ₹12.3 Lakh for FY 2024, up 112% year on year.
Ellex was founded in 1985 in Adelaide, Australia, within the ophthalmology sector. Ultrasound systems are developed by the company for ophthalmologists to diagnose and treat eye diseases. Products are offered for procedures including selective laser trabeculoplasty, canaloplasty, vitreolysis, capsulotomy, photocoagulation, and retinal rejuvenation. The canaloplasty business of iScience Interventional, a US-based firm, was acquired in 2014.
Ellex has made 1 acquisition, including iScience Interventional.
Ellex has 2 investors. Key investors include Quantel Medical, and business.gov.au.
Ellex operates through Lumibird Medical India Private Limited.
Yes. Ellex was acquired by Quantel Medical in July 2020.
The legal entities of Ellex currently have 2 directors, including Jean Marc Francis Gendre, Jatin Rameshchandra Desai.